Opportunities and Challenges of Genotyping Patients With Nephrotic Syndrome in the Genomic Era

Seminars in Nephrology

Volumn 35, Issue 3, 2015, Pages 212-221

  Sampson, Matthew G ^a   Pollak, Martin R ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Focal segmental glomerulosclerosis; Podocyte; Risk allele; SRNS

Indexed keywords

APOLIPOPROTEIN; LAMININ GAMMA1; NEPHRIN; PROTEIN APOL1; PROTEIN LMX1B; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; WT1 PROTEIN;

APOL1 GENE; CONGENITAL NEPHROTIC SYNDROME; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; HEREDITY; HLA DQA1 GENE; HUMAN; LAMB2 GENE; MONOGENIC DISORDER; NEPHROTIC SYNDROME; NPHS1 GENE; NPHS2 GENE; PLA2R1 GENE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; WT1 GENE; GENETICS; GENOMICS; GENOTYPE; PHENOTYPE; PROCEDURES;

GENETIC TESTING; GENOMICS; GENOTYPE; HUMANS; NEPHROTIC SYNDROME; PHENOTYPE;

EID: 84937972042     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2015.04.002     Document Type: Review

References (68)

1. Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease the National Academies Collection. Bethesda, MD: National Institutes of Health; 2011.
2. Koboldt D.C., Steinberg K.M., Larson D.E., Wilson R.K., Mardis E.R. The next-generation sequencing revolution and its impact on genomics. Cell 2013, 155:27-38.
3. Collins F.S., Varmus H. A new initiative on precision medicine. N Engl J Med 2015, 372:793-795.
4. Saleem M.A. New developments in steroid-resistant nephrotic syndrome. Pediatr Nephrol 2013, 28:699-709.
5. Genovese G., Friedman D.J., Ross M.D., Lecordier L., Uzureau P., et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010, 329:841-845.
6. Machuca E., Benoit G., Antignac C. Genetics of nephrotic syndrome: connecting molecular genetics to podocyte physiology. Hum Mol Genet 2009, 18:R185-R194.
7. Ruf R.G., Lichtenberger SM, Karle JP, Haas JP, Anacleto FE, Schultheiss M, et al. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol 2004, 15:722-732.
8. Buscher A.K., Kranz B., Büscher R., Hildebrandt F., Dworniczak B., Pennekamp P., et al. Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 2010, 5:2075-2084.
9. Jungraithmayr T.C., Hofer K., Cochat P., Chernin G., Cortina G., Fargue S., et al. Screening for NPHS2 mutations may help predict FSGS recurrence after transplantation. J Am Soc Nephrol 2011, 22:579-585.
10. Manolio T.A., Collins F.S., Cox N.J., Goldstein D.B., Hindorff L.A., Hunter D.J., et al. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753.
11. McCarthy H.J., Bierzynska A., Wherlock M., Ognjanovic M., Kerecuk L., Hegde S., et al. Simultaneous sequencing of 24 genes associated with steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 2013, 8:637-648.
12. Sadowski C.E., Lovric S., Ashraf S., Pabst W.L., Gee H.Y., Kohl S., et al. A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J Am Soc Nephrol 2015, 26:1279-1289.
13. Zenker M., Aigner T., Wendler O., Tralau T., Müntefering H., Fenski R., et al. Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum Mol Genet 2004, 13:2625-2632.
14. Pelletier J., Bruening W., Kashtan C.E., Mauer S.M., Manivel J.C., Striegel J.E., et al. Germline mutations in the Wilms[U+05F3] tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 1991, 67:437-447.
15. Barbaux S., Niaudet P., Gubler M.C., Grünfeld J.P., Jaubert F., Kuttenn F., et al. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet 1997, 17:467-470.
16. Dreyer S.D., Zhou G., Baldini A., Winterpacht A., Zabel B., Cole W., et al. Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome. Nat Genet 1998, 19:47-50.
17. Gbadegesin R., Hinkes B., Vlangos C., Mucha B., Liu J., Hopcian J., et al. Mutational analysis of NPHS2 and WT1 in frequently relapsing and steroid-dependent nephrotic syndrome. Pediatr Nephrol 2007, 22:509-513.
18. Giglio S., Provenzano A., Mazzinghi B., Becherucci F., Giunti L., Sansavini G., et al. Heterogeneous genetic alterations in sporadic nephrotic syndrome associate with resistance to immunosuppression. J Am Soc Nephrol 2015, 26:230-236.
19. Gbadegesin R.A., Winn M.P., Smoyer W.E. Genetic testing in nephrotic syndrome--challenges and opportunities. Nat Rev Nephrol 2013, 9:179-184.
20. Benoit G., Machuca E., Antignac C. Hereditary nephrotic syndrome: a systematic approach for genetic testing and a review of associated podocyte gene mutations. Pediatr Nephrol 2010, 25:1621-1632.
21. Manolio T.A. Bringing genome-wide association findings into clinical use. Nat Rev Genet 2013, 14:549-558.
22. Huyghe J.R., Jackson A.U., Fogarty M.P., Buchkovich M.L., Stančáková A., Stringham H.M., et al. Exome array analysis identifies new loci and low-frequency variants influencing insulin processing and secretion. Nat Genet 2013, 45:197-201.
23. Li Y., Sidore C., Kang H.M., Boehnke M., Abecasis G.R. Low-coverage sequencing: implications for design of complex trait association studies. Genome Res 2011, 21:940-951.
24. Lee S., Abecasis G.R., Boehnke M., Lin X. Rare-variant association analysis: study designs and statistical tests. Am J Hum Genet 2014, 95:5-23.
25. Gbadegesin R.A., Adeyemo A., Webb N.J., Greenbaum L.A., Abeyagunawardena A., Thalgahagoda S., et al. HLA-DQA1 and PLCG2 are candidate risk loci for childhood-onset steroid-sensitive nephrotic syndrome. J Am Soc Nephrol 2014, In press.
26. Stanescu H.C., Arcos-Burgos M., Medlar A., Bockenhauer D., Kottgen A., Dragomirescu L., et al. Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med 2011, 364:616-626.
27. Gharavi A.G., Kiryluk K., Choi M., Li Y., Hou P., Xie J., et al. Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet 2011, 43:321-327.
28. Okamoto K., Tokunaga K., Doi K., Fujita T., Suzuki H., Katoh T., et al. Common variation in GPC5 is associated with acquired nephrotic syndrome. Nat Genet 2011, 43:459-463.
29. Kiryluk K., Li Y., Scolari F., Sanna-Cherchi S., Choi M., Verbitsky M., et al. Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat Genet 2014, 46:1187-1196.
30. Locke A.E., Kahali B., Berndt S.I., Justice A.E., Pers T.H., Day F.R., et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 2015, 518:197-206.
31. Hivert M.F., Vassy J.L., Meigs J.B. Susceptibility to type 2 diabetes mellitus--from genes to prevention. Nat Rev Endocrinol 2014, 10:198-205.
32. Kopp J.B., Nelson G.W., Sampath K., Johnson R.C., Genovese G., An P., et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 2011, 22:2129-2137.
33. Kruzel-Davila E., Wasser W.G., Aviram S., Skorecki K. APOL1 nephropathy: from gene to mechanisms of kidney injury. Nephrol Dial Transplant 2015, In press.
34. Kopp J.B., Winkler C.A., Zhao X., Radeva M.K., Gassman J.J., D'Agati V.D., et al. Clinical features and histology of apolipoprotein L1-associated nephropathy in the FSGS clinical trial. J Am Soc Nephrol 2015, 26:1443-1448.
35. Parsa A., Kao W.H., Xie D., Astor B.C., Li M., Hsu C.Y., et al. APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med 2013, 369:2183-2196.
36. Reeves-Daniel A.M., DePalma J.A., Bleyer A.J., Rocco M.V., Murea M., Adams P.L., et al. The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant 2011, 11:1025-1030.
37. Lee B.T., Kumar V., Williams T.A., Abdi R., Bernhardy A., Dyer C., et al. The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival. Am J Transplant 2012, 12:1924-1928.
38. Palanisamy A., Reeves-Daniel A.M., Freedman B.I. The impact of APOL1, CAV1, and ABCB1 gene variants on outcomes in kidney transplantation: donor and recipient effects. Pediatr Nephrol 2014, 29:1485-1492.
39. Schrodi S.J., Mukherjee S., Shan Y., Tromp G., Sninsky J.J., Callear A.P., et al. Genetic-based prediction of disease traits: prediction is very difficult, especially about the future. Front Genet 2014, 5:162.
40. Lovric S., Fang H., Vega-Warner V., Sadowski C.E., Gee H.Y., Halbritter J., et al. Rapid detection of monogenic causes of childhood-onset steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 2014, 9:1109-1116.
41. MacArthur D.G., Manolio T.A., Dimmock D.P., Rehm H.L., Shendure J., Abecasis G.R., et al. Guidelines for investigating causality of sequence variants in human disease. Nature 2014, 508:469-476.
42. Brown E.J., Pollak M.R., Barua M. Genetic testing for nephrotic syndrome and FSGS in the era of next-generation sequencing. Kidney Int 2014, 85:1030-1038.
43. Lowik M.M., Groenen P.J., Levtchenko E.N., Monnens L.A., van den Heuvel L.P. Molecular genetic analysis of podocyte genes in focal segmental glomerulosclerosis--a review. Eur J Pediatr 2009, 168:1291-1304.
44. Lipska B.S., Iatropoulos P., Maranta R., Caridi G., Ozaltin F., Anarat A., et al. Genetic screening in adolescents with steroid-resistant nephrotic syndrome. Kidney Int 2013, 84:206-213.
45. Laurin L.P., Lu M., Mottl A.K., Blyth E.R., Poulton C.J., Weck K.E. Podocyte-associated gene mutation screening in a heterogeneous cohort of patients with sporadic focal segmental glomerulosclerosis. Nephrol Dial Transplant 2014, 29:2062-2069.
46. Rood I.M., Deegens J.K., Wetzels J.F. Genetic causes of focal segmental glomerulosclerosis: implications for clinical practice. Nephrol Dial Transplant 2012, 27:882-890.
47. Kestila M., Lenkkeri U., Männikkö M., Lamerdin J., McCready P., Putaala H., et al. Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome. Mol Cell 1998, 1:575-582.
48. Hinkes B.G., Mucha B., Vlangos C.N., Gbadegesin R., Liu J., Hasselbacher K., et al. Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics 2007, 119:e907-e919.
49. Buscher A.K., Konrad M., Nagel M., Witzke O., Kribben A., Hoyer P.F., et al. Mutations in podocyte genes are a rare cause of primary FSGS associated with ESRD in adult patients. Clin Nephrol 2012, 78:47-53.
50. Santin S., García-Maset R., Ruíz P., Giménez I., Zamora I., Peña A., et al. Nephrin mutations cause childhood- and adult-onset focal segmental glomerulosclerosis. Kidney Int 2009, 76:1268-1276.
51. Santin S., Bullich G., Tazón-Vega B., García-Maset R., Giménez I., Silva I., et al. Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 2011, 6:1139-1148.
52. Gilbert R.D., Turner C.L., Gibson J., Bass P.S., Haq M.R., Cross E., et al. Mutations in phospholipase C epsilon 1 are not sufficient to cause diffuse mesangial sclerosis. Kidney Int 2009, 75:415-419.
53. MacArthur D.G., Balasubramanian S., Frankish A., Huang N., Morris J., Walter K., et al. A systematic survey of loss-of-function variants in human protein-coding genes. Science 2012, 335:823-828.
54. Heeringa S.F., Vlangos C.N., Chernin G., Hinkes B., Gbadegesin R., Liu J., et al. Thirteen novel NPHS1 mutations in a large cohort of children with congenital nephrotic syndrome. Nephrol Dial Transplant 2008, 23:3527-3533.
55. Matejas V., Hinkes B., Alkandari F., Al-Gazali L., Annexstad E., Aytac M.B., et al. Mutations in the human laminin beta2 (LAMB2) gene and the associated phenotypic spectrum. Hum Mutat 2010, 31:992-1002.
56. Ovunc B., Ashraf S., Vega-Warner V., Bockenhauer D., Elshakhs N.A., Joseph M., et al. Mutation analysis of NPHS1 in a worldwide cohort of congenital nephrotic syndrome patients. Nephron Clin Pract 2012, 120:c139-c146.
57. Wong W., Morris M.C., Kara T. Congenital nephrotic syndrome with prolonged renal survival without renal replacement therapy. Pediatr Nephrol 2013, 28:2313-2321.
58. Hinkes B., Wiggins R.C., Gbadegesin R., Vlangos C.N., Seelow D., Nürnberg G., et al. Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet 2006, 38:1397-1405.
59. Tory K., Menyhárd D.K., Woerner S., Nevo F., Gribouval O., Kerti A., et al. Mutation-dependent recessive inheritance of NPHS2-associated steroid-resistant nephrotic syndrome. Nat Genet 2014, 46:299-304.
60. Begg C.B., Haile R.W., Borg A., Malone K.E., Concannon P., Thomas D.C., et al. Variation of breast cancer risk among BRCA1/2 carriers. JAMA 2008, 299:194-201.
61. Beutler E., Felitti V.J., Koziol J.A., Ho N.J., Gelbart T. Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002, 359:211-218.
62. Tennessen J.A., Bigham A.W., O'Connor T.D., Fu W., Kenny E.E., Gravel S., et al. Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science 2012, 337:64-69.
63. Xue Y., Chen Y., Ayub Q., Huang N., Ball E.V., Mort M., et al. Deleterious- and disease-allele prevalence in healthy individuals: insights from current predictions, mutation databases, and population-scale resequencing. Am J Hum Genet 2012, 91:1022-1032.
64. Flannick J., Beer N.L., Bick A.G., Agarwala V., Molnes J., Gupta N., et al. Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes. Nat Genet 2013, 45:1380-1385.
65. Jabbari J., Jabbari R., Nielsen M.W., Holst A.G., Nielsen J.B., Haunsø S., et al. New exome data question the pathogenicity of genetic variants previously associated with catecholaminergic polymorphic ventricular tachycardia. Circ Cardiovasc Genet 2013, 6:481-489.
66. Huynh Cong E., Bizet A.A., Boyer O., Woerner S., Gribouval O., Filhol E., et al. A homozygous missense mutation in the ciliary gene TTC21B causes familial FSGS. J Am Soc Nephrol 2014, 25:2435-2443.
67. Malone A.F., et al. Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis. Kidney Int 2014, 86:1253-1259.
68. Gadegbeku C.A., Gipson D.S., Holzman L.B., Ojo A.O., Song P.X., Barisoni L., et al. Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney Int 2013, 83:749-756.